Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study II

Breast Cancer Research

Volumn 14, Issue 2, 2012, Pages

  Rice, Megan S ^a,b   Tamimi, Rulla M ^a,b   Connolly, James L ^c   Collins, Laura C ^c   Shen, Dejun ^c   Pollak, Michael N ^d   Rosner, Bernard ^a,b   Hankinson, Susan E ^a,b   Tworoger, Shelley S ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; IGFBP3 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD SAMPLING; BREAST BIOPSY; BREAST CANCER; BREAST DISEASE; CANCER RISK; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PATHOLOGIST; QUESTIONNAIRE; REGISTERED NURSE; UNIVARIATE ANALYSIS; WOMEN'S HEALTH; BLOOD; MIDDLE AGED; PATHOLOGY; PREMENOPAUSE; UNITED STATES;

ADULT; BREAST DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; PREMENOPAUSE; UNITED STATES;

EID: 84857937065     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3141     Document Type: Article

References (25)

1. Russo J, Russo IH. Development of the human breast. Maturitas 2004, 49:2-15. 10.1016/j.maturitas.2004.04.011, 15351091.
2. Russo J, Russo IH. Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev 1994, 3:353-364.
3. Baer HJ, Collins LC, Connolly JL, Colditz GA, Schnitt SJ, Tamimi RM. Lobule type and subsequent breast cancer risk: results from the Nurses' Health Studies. Cancer 2009, 115:1404-1411. 10.1002/cncr.24167, 2661011, 19170235.
4. Milanese TR, Hartmann LC, Sellers TA, Frost MH, Vierkant RA, Maloney SD, Pankratz VS, Degnim AC, Vachon CM, Reynolds CA, Thompson RA, Melton LJ, Goode EL, Visscher DW. Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst 2006, 98:1600-1607. 10.1093/jnci/djj439, 17105983.
5. McKian KP, Reynolds CA, Visscher DW, Nassar A, Radisky DC, Vierkant RA, Degnim AC, Boughey JC, Ghosh K, Anderson SS, Minot D, Caudill JL, Vachon CM, Frost MH, Pankratz VS, Hartmann LC. Novel breast tissue feature strongly associated with risk of breast cancer. J Clin Oncol 2009, 27:5893-5898. 10.1200/JCO.2008.21.5079, 2793038, 19805686.
6. Neuenschwander S, Schwartz A, Wood TL, Roberts CT, Hennighausen L, LeRoith D. Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model. J Clin Invest 1996, 97:2225-2232. 10.1172/JCI118663, 507301, 8636401.
7. Pollak MN, Schernhammer ES, Hankinson SE. Insulin-like growth factors and neoplasia. Nat Rev Cancer 2004, 4:505-518. 10.1038/nrc1387, 15229476.
8. Kelley KM, Oh Y, Gargosky SE, Gucev Z, Matsumoto T, Hwa V, Ng L, Simpson DM, Rosenfeld RG. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol 1996, 28:619-637. 10.1016/1357-2725(96)00005-2, 8673727.
9. Yakar S, Leroith D, Brodt P. The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: lessons from animal models. Cytokine Growth Factor Rev 2005, 16:407-420. 10.1016/j.cytogfr.2005.01.010, 15886048.
10. Key TJ, Appleby PN, Reeves GK, Roddam AW. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 11:530-542.
11. Byrne C, Colditz GA, Willett WC, Speizer FE, Pollak M, Hankinson SE. Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Res 2000, 60:3744-3748.
12. Schernhammer ES, Tworoger SS, Eliassen AH, Missmer SA, Holly JM, Pollak MN, Hankinson SE. Body shape throughout life and correlations with IGFs and GH. Endocr Relat Cancer 2007, 14:721-732. 10.1677/ERC-06-0080, 17914102.
13. Tworoger SS, Sluss P, Hankinson SE. Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. Cancer Res 2006, 66:2476-2482. 10.1158/0008-5472.CAN-05-3369, 16489055.
14. Su X, Colditz GA, Willett WC, Collins LC, Schnitt SJ, Connolly JL, Pollak MN, Rosner B, Tamimi RM. Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease. Int J Cancer 126:180-190.
15. Rosner B. Percentage points for a generalized ESD many-outlier procedure. Technometrics 1983, 25:165-172.
16. Radisky DC, Hartmann LC. Mammary involution and breast cancer risk: transgenic models and clinical studies. J Mammary Gland Biol Neoplasia 2009, 14:181-191. 10.1007/s10911-009-9123-y, 2693781, 19404726.
17. Ramakrishnan R, Gann PH, Wiley EL, Khurana KK, Khan SA. Normal breast lobular architecture in breast biopsy samples from breast cancer cases and benign disease controls. Breast Cancer Res Treat 2004, 86:259-268. 10.1023/B:BREA.0000036899.97114.b3, 15567942.
18. Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, Hoover R, Haile R. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 1995, 87:1622-1629. 10.1093/jnci/87.21.1622, 7563205.
19. Boyd NF, Lockwood GA, Martin LJ, Byng JW, Yaffe MJ, Tritchler DL. Mammographic density as a marker of susceptibility to breast cancer: a hypothesis. IARC Sci Publ 2001, 154:163-169.
20. Ghosh K, Hartmann LC, Reynolds C, Visscher DW, Brandt KR, Vierkant RA, Scott CG, Radisky DC, Sellers TA, Pankratz VS, Vachon CM. Association between mammographic density and age-related lobular involution of the breast. J Clin Oncol 28:2207-2212.
21. Diorio C, Pollak M, Byrne C, Masse B, Hebert-Croteau N, Yaffe M, Cote G, Berube S, Morin C, Brisson J. Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density. Cancer Epidemiol Biomarkers Prev 2005, 14:1065-1073. 10.1158/1055-9965.EPI-04-0706, 15894654.
22. Boyd NF, Stone J, Martin LJ, Jong R, Fishell E, Yaffe M, Hammond G, Minkin S. The association of breast mitogens with mammographic densities. Br J Cancer 2002, 87:876-882. 10.1038/sj.bjc.6600537, 2376176, 12373602.
23. Maskarinec G, Takata Y, Chen Z, Gram IT, Nagata C, Pagano I, Hayashi K, Arendell L, Skeie G, Rinaldi S, Kaaks R. IGF-I and mammographic density in four geographic locations: a pooled analysis. Int J Cancer 2007, 121:1786-1792. 10.1002/ijc.22834, 17520679.
24. Aiello EJ, Tworoger SS, Yasui Y, Stanczyk FZ, Potter J, Ulrich CM, Irwin M, McTiernan A. Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2005, 14:1411-1417. 10.1158/1055-9965.EPI-04-0920, 15941949.
25. Vierkant RA, Hartmann LC, Pankratz VS, Anderson SS, Radisky D, Frost MH, Vachon CM, Ghosh K, Distad TJ, Degnim AC, Reynolds CA. Lobular involution: localized phenomenon or field effect?. Breast Cancer Res Treat 2009, 117:193-196. 10.1007/s10549-008-0082-6, 2904055, 18592369.